Amphastar Pharmaceuticals (AMPH) Retained Earnings (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Retained Earnings of $673.3 million for Q1 2026, up 13.34% year-over-year from $594.1 million in Q1 2025, and up 0.96% quarter-over-quarter from $666.9 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Retained Earnings (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Retained Earnings history runs 14 years deep, the most recent figure standing at $673.3 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 13.34% year-over-year to $673.3 million; the TTM figure through Mar 2026 stood at $673.3 million (up 13.34% YoY), while the FY2025 annual figure was $666.9 million, up 31.95% from the prior year.
- Retained Earnings for Q1 2026 stood at $673.3 million, up from $666.9 million in the prior quarter.
- The five-year high for Retained Earnings was $673.3 million in Q1 2026, with the low at -$9.9 million in Q3 2022.
- The 5-year median for Retained Earnings is $456.6 million (2023), against an average of $393.8 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 102.41% in 2022, then surged 6402.59% in 2023.
- Amphastar Pharmaceuticals' Retained Earnings stood at $271.7 million in 2022, then surged by 50.62% to $409.3 million in 2023, then increased by 23.49% to $505.4 million in 2024, then surged by 31.95% to $666.9 million in 2025, then advanced by 0.96% to $673.3 million in 2026.
- Business Quant data shows AMPH's Retained Earnings at $673.3 million in Q1 2026, $666.9 million in Q4 2025, and $642.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Amphastar Pharmaceuticals | 949.26 Mn | 659.13 Mn | 93.47 Mn | 703.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 703.65 Mn |
| Mar 31, 2026 | 673.30 Mn |
| Dec 31, 2025 | 666.88 Mn |
| Sep 30, 2025 | 642.45 Mn |
| Jun 30, 2025 | -5.36 Mn |
| Mar 31, 2025 | 594.07 Mn |
| Dec 31, 2024 | 505.40 Mn |
| Sep 30, 2024 | 530.82 Mn |
| Jun 30, 2024 | 490.39 Mn |
| Mar 31, 2024 | 452.45 Mn |
| Dec 31, 2023 | 409.27 Mn |
| Sep 30, 2023 | 477.88 Mn |
| Jun 30, 2023 | 323.88 Mn |
| Mar 31, 2023 | 456.62 Mn |
| Dec 31, 2022 | 271.72 Mn |
| Sep 30, 2022 | -9.93 Mn |
| Jun 30, 2022 | 221.94 Mn |
| Mar 31, 2022 | -7.25 Mn |
| Dec 31, 2021 | 422.42 Mn |
| Sep 30, 2021 | 412.92 Mn |